Guardian Partners Inc. Eli Lilly & CO Transaction History
Guardian Partners Inc.
- $983 Billion
- Q4 2024
A detailed history of Guardian Partners Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Guardian Partners Inc. holds 4,187 shares of LLY stock, worth $3.62 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
4,187Holding current value
$3.62 Million% of portfolio
0.34%Shares
1 transactions
Others Institutions Holding LLY
# of Institutions
4,139Shares Held
743MCall Options Held
8.35MPut Options Held
10.2M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$83.8 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA74.2MShares$64.2 Billion1.03% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$57 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$44.4 Billion26.72% of portfolio
-
State Street Corp Boston, MA33.9MShares$29.3 Billion1.24% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $822B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...